70 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Parathyroid Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Condition: Parathyroid Disease
Intervention: Drug: FACBC
2 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
Intervention:
3 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
4 Not yet recruiting Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Condition: Secondary Hyperparathyroidism-Chronic Kidney Disease
Interventions: Drug: Doxercalciferol (GZ427397);   Drug: Calcitriol
5 Recruiting Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera
Condition: Primary Hyperparathyroidism
Intervention: Device: Tomoscintigraphic parathyroid imaging on a CZT camera
6 Not yet recruiting Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)
Condition: Primary Hyperthyroidism
Interventions: Device: PET-MR;   Device: PET-CT
7 Recruiting Survey on Epidemiology of Hypoparathyroidism in France
Condition: Hypoparathyroidism
Intervention: Other: No intervention
8 Not yet recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
9 Not yet recruiting A Single-dose Study in Paediatric Subjects Aged 2 to Less Than 18 Years With (sHPT) Receiving Haemodialysis
Condition: Chronic Kidney Disease, Secondary Hyperparathyroidism
Intervention: Drug: Study Drug
10 Not yet recruiting Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass
Conditions: Roux-en-Y Gastric Bypass;   Hyperparathyroidism, Secondary
Interventions: Dietary Supplement: Calcium Carbonate;   Dietary Supplement: Calcium Citrate;   Dietary Supplement: Placebo;   Procedure: Roux-en-Y gastric bypass
11 Recruiting Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
12 Not yet recruiting Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism
Condition: Hypoparathyroidism
Interventions: Drug: 25mcg rhPTH(1-84);   Drug: 50mcg rhPTH(1-84);   Drug: 100mcg rhPTH(1-84)
13 Recruiting Insulin Resistance in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism;   Diabetes;   Hypercalcemia
Intervention: Procedure: parathyroidectomy
14 Recruiting Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy
Condition: Transient Hypoparathyroidism
Interventions: Drug: phosphate and betamethasone acetate, 2 mL.;   Drug: saline 0.9% NaCl
15 Recruiting Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
Condition: Hyperparathyroidism
Intervention: Procedure: NO hydrochlorothiazide (HCTZ)
16 Recruiting Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
Condition: Renal Osteodystrophy
Intervention:
17 Recruiting Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
Conditions: Idiopathic Hypoparathyroidism;   Autosomal Dominant Hypocalcaemia;   Pseudohypoparathyroidism
Intervention:
18 Recruiting Phase 3 Study of KHK7580
Condition: Secondary Hyperparathyroidism
Intervention: Drug: KHK7580
19 Recruiting Phase 3 Study of KHK7580
Condition: Secondary Hyperparathyroidism
Intervention: Drug: KHK7580
20 Recruiting Phase 3 Study of KHK7580
Condition: Secondary Hyperparathyroidism
Interventions: Drug: KHK7580;   Drug: KRN1493

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years